Skip to search.
 BSE Down0.56% NSE Down0.70%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS

259.96 Down 3.68(1.40%) 1:30AM|After Hours : 261.88 Up 1.92 (0.74%) 3:16AM - Nasdaq Real Time Price

Add to Portfolio
Industry: BiotechnologyGet Industry for:
REGN Sector / Industry Membership
Sector:Healthcare
Industry:Biotechnology
Intraday Performance Summary
NameTickerChange
Chart for Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc.REGNDown1.40%

Top Biotechnology Companies by Market Cap
CompanySymbolPriceChangeMarket CapP/E
Roche Holding AGRHHBYN.MX782.80Up0.14%2.66T261.98
Shire plcSHP.L2,135.00Up2.35%11.77B2,093.14
Sun Pharmaceuticals Industries Ltd.SUNPHARMA.NS973.95Up0.83%1.01T35.84
Gilead Sciences Inc.GILD.MX698.00Up2.12%1.06T390.82
Amgen Inc.AMGN.MX1,296.49Up0.23%972.34B219.45
Regeneron Pharmaceuticals, Inc.REGN259.96Down1.40%25.18B34.76
REGN vs. Industry Leaders
StatisticIndustry LeaderREGNREGN Rank
Market CapitalizationRHHBYN.MX2.66T25.18B24 / 436
P/E Ratio (ttm)GNS.L2,287.0734.7617 / 436
PEG Ratio (ttm, 5 yr expected)MSB.AX11.582.2911 / 436
Revenue Growth (Qtrly YoY)PA8.DE997.70%89.70%41 / 436
EPS Growth (Qtrly YoY)BSTC72.70%718.20%3 / 436
Long-Term Growth Rate (5 yr)INCY93.70%31.57%13 / 436
Return on Equity (ttm)PA8.DE211.92%87.68%5 / 436
Long-Term Debt/Equity (mrq)32.904N/A
Dividend Yield (annual)NPC.TO17.40%N/AN/A

Currency in USD.